Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Tulloh

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Pediatrics|May 7, 2020
Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemicAshraf S Harahsheh, Nagib Dahdah, Jane W Newburger, et al.
International Journal of Cardiology|June 25, 2021
Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative studyLaion R A Gonzaga, Walter J Gomes, Isadora S Rocco, et al.
The Lancet. Child & Adolescent Health|September 21, 2020
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi processRachel Harwood, Benjamin Allin, Christine E Jones, et al.
Trials|January 26, 2023
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocolDespina Eleftheriou, Yolanda Collaco Moraes, Cara Purvis, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Pediatrics|May 7, 2020
Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemicAshraf S Harahsheh, Nagib Dahdah, Jane W Newburger, et al.
International Journal of Cardiology|June 25, 2021
Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative studyLaion R A Gonzaga, Walter J Gomes, Isadora S Rocco, et al.
The Lancet. Child & Adolescent Health|September 21, 2020
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi processRachel Harwood, Benjamin Allin, Christine E Jones, et al.
Trials|January 26, 2023
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocolDespina Eleftheriou, Yolanda Collaco Moraes, Cara Purvis, et al.
Pageof 5